JR I thought you had a back ground in finance
If not please advise .
There’s an exclusivity clock running
Currently Germany will not reimburse for Vazkepa
France, Spain and Italy are currently in negotiations.
Leading Cardiologists in France are advocating for reimbursement so there’s a good chance there
Even if France , Italy and Spain agree to reimburse , its at least 2 yrs before KM and team will get those markets to breakeven
NVS with an established CAD sales infrastructure in the EU will do it far faster …. And Denner is the one to make that deal happen if he had those major EU countries providing reimbursement
JMO
Could be wrong and hope U all become gazillionaires
Kiwi
Market Data 
Markets 
AI
